Genomics Medicine Ireland (GMI) is to create 600 high-skilled jobs over the next five years in Dublin.
This is a result of a €350 million investment programme that will benefit the life sciences company.
GMI plans to use the programme to research and discover new precision medicines for the treatment of life-limiting conditions which currently have no cure.
Founded in 2015, GMI carries out genomic research into a range of diseases such as Multiple Sclerosis, Alzheimer’s disease, brain tumours and inflammatory bowel disease.
For more on this story, see thejournal.ie. Search careers at GMI by following this link.